![Stephen Biggar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Biggar
Président chez
ACADIA PHARMACEUTICALS INC.
Fortune : 2 M $ au 31/05/2026
Profil
Le Dr Stephen R. Biggar est un directeur indépendant de TScan Therapeutics, Inc. et de Kiniksa Pharmaceuticals Ltd. et un président d'ACADIA Pharmaceuticals, Inc. Il siège aux conseils d'administration de TScan Therapeutics, Inc. et de Kiniksa Pharmaceuticals Ltd. et de Vivelix Pharmaceuticals, Ltd. Le Dr Biggar était auparavant employé en tant que directeur indépendant par Synageva BioPharma Corp. et partenaire de Baker Bros. Advisors LP. Il a également siégé au conseil d'administration de BioCryst Pharmaceuticals, Inc. et de Synageva BioPharma Corp. /Old/. Il a obtenu son diplôme de premier cycle à l'Université de Rochester, un diplôme d'études supérieures à l'Université de Stanford et un doctorat à l'Université de Stanford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/02/2026 | 61 541 ( 0,04% ) | 1 M $ | 31/05/2026 | |
0,03% | 06/04/2026 | 12 546 ( 0,03% ) | 606 975 $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Stephen Biggar
| Sociétés | Poste | Début |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Président | 10/06/2016 |
| TSCAN THERAPEUTICS, INC. | Président | 12/06/2024 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Directeur/Membre du Conseil | 01/10/2015 |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops cell therapies for the treatment of diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Stephen Biggar
| Sociétés | Poste | Fin |
|---|---|---|
| SYNAGEVA BIOPHARMA CORP | Directeur/Membre du Conseil | 22/06/2015 |
Synageva BioPharma Corp. /Old/
 Synageva BioPharma Corp. /Old/ BiotechnologyHealth Technology Manufactures biopharmaceutical products | Directeur/Membre du Conseil | 04/11/2011 |
| BIOCRYST PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 10/10/2011 |
Vivelix Pharmaceuticals, Ltd.
 Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Directeur/Membre du Conseil | - |
Formation de Stephen Biggar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities. | Finance |
Synageva BioPharma Corp. /Old/
Synageva BioPharma Corp. /Old/ BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Vivelix Pharmaceuticals, Ltd.
Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops cell therapies for the treatment of diseases | Health Technology |
